How to stop vaping

Published 6 September 2026 · 6 min read

By Loutra · Sources (6)

Nobody has a protocol for this yet

Start with the part that gets left out. The Cochrane review of everything ever tried to help people stop vaping opens on this sentence: "There is limited guidance on the best ways to stop nicotine vaping."

Its authors are blunter still about the official position in the UK. NICE guidance, they note, recommends that the NHS support people who vape to stop "when they are ready to do so, but does not set out how best to achieve this."

That is not an admission of ignorance from people who did not look. It is the state of the field, and the gap is measurable: on weight gain after quitting smoking we have a meta-analysis of 62 clinical trials and a Cochrane review covering 120. Here is what we have on quitting vaping.

Everything ever tested fits into fifteen trials

The count is exact and it is recent. Interventions for quitting vaping is a living review — searched monthly, current to 1 July 2025 — and it has gathered every randomised trial ever run on the question: fifteen studies, 5,800 participants. Fourteen in the United States, one in Italy. None in the UK. Five judged at low risk of bias, six at high.

And within that total, the method you will read everywhere — drop the nicotine strength, stretch out the gaps — occupies a place nobody expects.

The advice everyone gives you is the least tested thing on the list

The NHS devotes a full page to quitting vaping, and it is the best freely available guide there is. It offers two routes. The first is gradual, in three moves: check your e-liquid's nicotine content in mg/ml and "gradually reduce it over time, paying attention to how you feel"; stretch the intervals — "if you normally vape every 20 minutes, try to extend that time and only vape every 40 minutes instead"; and build vape-free zones, "places or times where you won't vape, like at work or inside certain rooms in your home."

All of it is sensible. All of it is also the seventeen-person strategy above. Absence of evidence is not evidence of absence: this does not mean it fails, it means nobody has checked. So treat it as a hypothesis you are testing on yourself rather than a protocol. The NHS supplies the one early failure signal available: "If you find yourself vaping more, it may be a sign that you've reduced your nicotine level too quickly."

What has actually been measured: being prompted every day

The one solid result in the whole review is for text message support programmes. In 13 to 24 year olds, they raise quit rates against no or minimal support: risk ratio 1.32, 95% CI 1.19 to 1.47, across two studies and 4,091 participants.

The raw numbers from the larger trial reframe the subject. Among 2,588 American young adults aged 18 to 24 who wanted to stop, seven months later 24.1% of the supported group had quit, against 18.6% of the control group. That is real and statistically solid, and it still leaves three people in four who did not get there using the best-documented tool in the field.

Two caveats, both raised by Cochrane itself: the two trials tested the same programme, funded by the organisation that supplies it, and only in young people. So we do not know whether it generalises to another programme, or to a 40-year-old who has vaped for eight years. What transfers is not the tool but its shape — something daily, that comes to you rather than waiting for you to remember it.

The medicines, and what they are worth

Two stop-smoking drugs have been tried against placebo in people who vape, and these are the frankest results in the review.

Varenicline comes out at a risk ratio of 2.71 (95% CI 1.33 to 5.49) across two trials and 315 participants — low certainty, because of imprecision. The 2025 JAMA trial, run in 261 young people aged 16 to 25 who vaped daily and did not smoke, gives the raw figures: 51% abstinent against 14% on placebo at the end of treatment, and 28% against 7% at six months, with everyone also receiving counselling.

Cytisinicline was tested in 160 adults who vaped: 31.8% abstinent against 15.1% at the end of treatment. Four weeks later the gap narrows to 23.4% against 13.2% and is no longer statistically significant — the authors themselves conclude the result "needs confirmation in a larger trial with longer follow-up."

Both are prescription medicines, and none of this is a decision to make alone. Worth noting what did not show an effect: combination nicotine replacement, patch plus a fast form, came out at a risk ratio of 0.96 across two trials.

What the NHS says exactly

Before any of the technique, the NHS puts a box marked "Important!" at the top of its page, and it is the most useful sentence in this article:

"You may experience withdrawal symptoms when you quit nicotine vapes. This might make you want to reach for a cigarette. You should only quit vaping if you are confident you can do it without smoking cigarettes."

Quitting vaping, in other words, does not outrank not smoking. The NHS repeats the ranking for slips — "going back to vaping is much better than starting to smoke again" — while keeping the destination in view: "the healthiest option is not to smoke or vape."

There is a reason to take that seriously beyond common sense. Cochrane went looking for exactly this risk — whether a vaping cessation programme pushes people towards cigarettes — and found that one single trial has ever measured smoking uptake, with a result too uncertain to conclude anything from. The authors close by asking future studies to measure smoking outcomes "so the complete risk profile of relevant interventions can be considered." Nobody can currently promise you that trade-off is safe. The NHS handles it by making the order explicit, and so should you.

Where to start

There is a simple measure of your dependence and it needs no equipment: the time between waking up and your first puff. In the American trial, 82.3% of participants vaped within thirty minutes of waking — and among them, quit rates at seven months were markedly lower than among those who lasted longer in the morning. If you vape before you are out of bed, that is not a willpower defect. It is a heavier dependence, and it needs more help than average.

The rest is three decisions. Pick your route, tapered or clean, knowing neither has been shown to beat the other. Make the device less available — the one concrete move the NHS puts in its own list, and the cheapest thing on it. And book a real appointment if you have vaped for years, precisely because there is no off-the-shelf protocol to follow.

Loutra replaces neither that appointment nor a treatment. It does the one thing the Cochrane review points to as useful that does not depend on anyone else: prompting you every day, counting the days, and keeping your history when a day goes badly. It is not much. On this particular subject, it is close to everything we have evidence for.

Questions people ask

Loutra is free on the App Store

An otter that’s counting on you, a daily check-in, and a breathing round for the minutes that are hard.